Real-time Continuous Glucose Monitoring, Blood Sugar Control

JAMA

EMBARGOED FOR RELEASE: 3:15 P.M. (ET), WEDNESDAY, JUNE 2, 2021

Media advisory: The full study and editorial are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.6530?guestAccessKey=334cacbe-c25b-4ff6-bbc6-d4c7015513e9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=060221

 

What The Study Did: Researchers investigated the effect of real-time continuous glucose monitoring on glycemic control among patients with insulin-treated diabetes.

Authors: Andrew J. Karter, Ph.D., of Kaiser Permanente in Oakland, California, is the corresponding author.

 

(doi:10.1001/jama.2021.6530)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.